Cargando…

Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma

INTRODUCTION: To depict the genomic landscape of Chinese early-stage lung squamous cell carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 expression, and immune infiltrates. METHODS: Whole-exome sequencing was performed on 189 surgically resected LUSC. TMB was...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tao, Shi, Jinpeng, Dong, Zhengwei, Hou, Likun, Zhao, Chao, Li, Xuefei, Mao, Beibei, Zhu, Wei, Guo, Xianchao, Zhang, Henghui, He, Ji, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Wu, Chunyan, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625041/
https://www.ncbi.nlm.nih.gov/pubmed/31299995
http://dx.doi.org/10.1186/s13045-019-0762-1
_version_ 1783434336568082432
author Jiang, Tao
Shi, Jinpeng
Dong, Zhengwei
Hou, Likun
Zhao, Chao
Li, Xuefei
Mao, Beibei
Zhu, Wei
Guo, Xianchao
Zhang, Henghui
He, Ji
Chen, Xiaoxia
Su, Chunxia
Ren, Shengxiang
Wu, Chunyan
Zhou, Caicun
author_facet Jiang, Tao
Shi, Jinpeng
Dong, Zhengwei
Hou, Likun
Zhao, Chao
Li, Xuefei
Mao, Beibei
Zhu, Wei
Guo, Xianchao
Zhang, Henghui
He, Ji
Chen, Xiaoxia
Su, Chunxia
Ren, Shengxiang
Wu, Chunyan
Zhou, Caicun
author_sort Jiang, Tao
collection PubMed
description INTRODUCTION: To depict the genomic landscape of Chinese early-stage lung squamous cell carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 expression, and immune infiltrates. METHODS: Whole-exome sequencing was performed on 189 surgically resected LUSC. TMB was defined as the sum of nonsynonymous single nucleotide and indel variants. CD8(+) tumor-infiltrating lymphocyte (TIL) density and PD-L1 expression were evaluated by immunohistochemistry. Six immune infiltrates were estimated using an online database. RESULTS: The median TMB was 9.43 mutations per megabase. Positive PD-L1 expression and CD8(+) TILs density were identified in 24.3% and 78.8%. PIK3CA amplification was associated with significantly higher TMB (P = 0.036). Frequent genetic alterations had no impact on PD-L1 expression but PIK3CA amplification and KEAP1 mutation were independently associated with significantly lower CD8(+) TIL density (P < 0.001, P = 0.005, respectively). Low TMB and high CD8(+) TIL density were independently associated with longer disease-free survival (DFS) while none of them could individually predict the overall survival (OS). Combination of TMB and PD-L1 expression or TMB and CD8(+) TIL density could stratify total populations into two groups with distinct prognosis. Classifying tumor-immune microenvironment based on PD-L1 expression and CD8(+) TIL density showed discrepant genomic alterations but similar TMB, clinical features, and OS. Notably, patients with different smoking status had distinct prognostic factors. CONCLUSION: The combination of TMB, PD-L1 expression, immune infiltrates, and smoking status showed the feasibility to subgroup stratification in Chinese patients with early-stage LUSC, which might be helpful for future design of personalized immunotherapy trials in LUSC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-019-0762-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6625041
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66250412019-07-23 Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma Jiang, Tao Shi, Jinpeng Dong, Zhengwei Hou, Likun Zhao, Chao Li, Xuefei Mao, Beibei Zhu, Wei Guo, Xianchao Zhang, Henghui He, Ji Chen, Xiaoxia Su, Chunxia Ren, Shengxiang Wu, Chunyan Zhou, Caicun J Hematol Oncol Research INTRODUCTION: To depict the genomic landscape of Chinese early-stage lung squamous cell carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 expression, and immune infiltrates. METHODS: Whole-exome sequencing was performed on 189 surgically resected LUSC. TMB was defined as the sum of nonsynonymous single nucleotide and indel variants. CD8(+) tumor-infiltrating lymphocyte (TIL) density and PD-L1 expression were evaluated by immunohistochemistry. Six immune infiltrates were estimated using an online database. RESULTS: The median TMB was 9.43 mutations per megabase. Positive PD-L1 expression and CD8(+) TILs density were identified in 24.3% and 78.8%. PIK3CA amplification was associated with significantly higher TMB (P = 0.036). Frequent genetic alterations had no impact on PD-L1 expression but PIK3CA amplification and KEAP1 mutation were independently associated with significantly lower CD8(+) TIL density (P < 0.001, P = 0.005, respectively). Low TMB and high CD8(+) TIL density were independently associated with longer disease-free survival (DFS) while none of them could individually predict the overall survival (OS). Combination of TMB and PD-L1 expression or TMB and CD8(+) TIL density could stratify total populations into two groups with distinct prognosis. Classifying tumor-immune microenvironment based on PD-L1 expression and CD8(+) TIL density showed discrepant genomic alterations but similar TMB, clinical features, and OS. Notably, patients with different smoking status had distinct prognostic factors. CONCLUSION: The combination of TMB, PD-L1 expression, immune infiltrates, and smoking status showed the feasibility to subgroup stratification in Chinese patients with early-stage LUSC, which might be helpful for future design of personalized immunotherapy trials in LUSC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13045-019-0762-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-12 /pmc/articles/PMC6625041/ /pubmed/31299995 http://dx.doi.org/10.1186/s13045-019-0762-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jiang, Tao
Shi, Jinpeng
Dong, Zhengwei
Hou, Likun
Zhao, Chao
Li, Xuefei
Mao, Beibei
Zhu, Wei
Guo, Xianchao
Zhang, Henghui
He, Ji
Chen, Xiaoxia
Su, Chunxia
Ren, Shengxiang
Wu, Chunyan
Zhou, Caicun
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
title Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
title_full Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
title_fullStr Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
title_full_unstemmed Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
title_short Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
title_sort genomic landscape and its correlations with tumor mutational burden, pd-l1 expression, and immune cells infiltration in chinese lung squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625041/
https://www.ncbi.nlm.nih.gov/pubmed/31299995
http://dx.doi.org/10.1186/s13045-019-0762-1
work_keys_str_mv AT jiangtao genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT shijinpeng genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT dongzhengwei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT houlikun genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT zhaochao genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT lixuefei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT maobeibei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT zhuwei genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT guoxianchao genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT zhanghenghui genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT heji genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT chenxiaoxia genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT suchunxia genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT renshengxiang genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT wuchunyan genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma
AT zhoucaicun genomiclandscapeanditscorrelationswithtumormutationalburdenpdl1expressionandimmunecellsinfiltrationinchineselungsquamouscellcarcinoma